AAON is engaged in the manufacture and sale of air conditioning and heating equipment consisting of standard, semi-custom and custom rooftop units, chillers, packaged outdoor mechanical rooms, air handling units, makeup air units, energy recovery units, condensing units, geothermal/water-source heat pumps and coils. These products are marketed and sold to retail, manufacturing, educational, lodging, supermarket, medical and other commercial industries. The company's of rooftop units include the RQ Series, the RN Series, the RL Series and the RZ Series. The company's condensing units include the CB Series, the CF Series, the CN Series, and the CL Series.

Agnico-Eagle Mines is a gold mining company with mining operations in Canada, Mexico and Finland. Co. earns a proportion of its revenues from the production and sale of gold in both dore bar and concentrate form. The remainder of revenue and cash flow is generated by the production and sale of byproduct metals. The revenue from byproduct metals is mainly generated by production at the LaRonde mine in Canada (silver, zinc, copper and lead) and the Pinos Altos mine in Mexico (silver).

American Woodmark manufactures and distributes kitchen, bath and home organization products for the remodeling and new home construction markets. The company provides a variety of products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization and hardware. The company's cabinetry products are available in a variety of designs, finishes and finish colors and door styles. The company provides products in the following categories: made-to-order, which are special ordered and shipped directly to the home from the factory; and stock, which represents cash and carry products sold through home centers. The company's home organization products are stock products.

AptarGroup is a supplier of a range of dispensing, sealing and active packaging solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food and beverage markets. The company's primary products are dispensing pumps, which dispense a spray or lotion from non-pressurized containers; closures, which are plastic caps that allow a product to be dispensed without removing the cap; aerosol valves, which dispense product from pressurized containers; and elastomeric primary packaging components, which include stoppers for infusion, antibiotic, lyophilization and diagnostic vials, pre-filled syringe components, as well as dropper bulbs and syringe plungers.

Avanos Medical is a medical technology company focused on delivering medical device products with manufacturing facilities in the United States, Mexico, France, Germany and Tunisia. The company provides a portfolio of product offerings focused on chronic care and pain management. Chronic Care product includes: digestive health products such as Mic-Key enteral feeding tubes, and Corpak patient feeding solutions; and respiratory health products such as closed airway suction systems. Pain Management product includes: acute pain products such as On-Q and ambIT surgical pain pumps; and interventional pain solutions, which provides minimally invasive pain relieving therapies.

BMTC Group is a holding company. Co. manages and operates a retail sales network of furniture and household and electronic appliances in Quebec. As of Dec 31 2011, Co.'s sales and distribution network includes 20 stores, 6 liquidation centers and 6 Brault & Martineau Sleep Gallery centers located in the areas of Montreal, Repentigny, Ste-Therese, Laval, Kirkland, Quebec, St-Georges, Trois-Rivieres, Sherbrooke, Chicoutimi, Riviere-du-Loup, Rimouski, Levis, Beauport, Ste-Foy, Gatineau, Ste-Hyacinthe, St-Jean-sur-le-Richelieu, Granby, Vaudreuil, Mascouche and St-Jerome. The network also includes two distribution and administrative centers in Montreal and Quebec City.

Boise Cascade is a wood products manufacturer and building materials distributor. The company's line of products is used primarily in new residential construction, residential repair-and-remodeling projects, light commercial construction, and industrial applications. The company has two reportable segments. The company's Wood Products segment manufactures laminated veneer lumber, I-joists, and laminated beams, which are collectively referred to as engineered wood products (EWP). The company's Building Materials Distribution segment sells a line of building materials, including oriented strand board, plywood, lumber, general line items such as siding, composite decking, metal products, insulation, and roofing, and EWP.

Cal-Maine Foods is a producer and marketer of shell eggs. The company has one operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs. The company sells most of its shell eggs in the southwestern, southeastern, mid-western and mid-Atlantic regions of the U.S. through its distribution network to a group of customers, including national and regional grocery store chains, club stores, foodservice distributors and egg product consumers. The company markets cage-free eggs under its trademarked Farmhouse? brand and distributes them across the southeast and southwest regions of the U.S. The company markets organic, cage-free, vegetarian, and omega-3 eggs under its 4-Grain? brand.

Canopy Growth is a licensed producer of medical marijuana in Canada. The principal activities of Co. are the production and sale of marijuana out of its facility in Smiths Falls, Ontario as regulated by the "Marijuana for Medical Purposes Regulations".

Compugen is a therapeutic discovery company based in Isreal. Co. is engaged in utilizing its broadly applicable predictive discovery infrastructure to discover novel drug targets and develop first-in-class therapeutics. Co. is advancing a therapeutic pipeline consisting mainly of early-stage immuno-oncology programs, aimed at harnessing the immune system to eradicate cancer. Co.'s pipeline is based on novel Compugen-discovered drug targets, primarily immune checkpoint candidates that are predicted to provide cancer immunotherapies addressing unmet cancer types and patient populations, both as monotherapy and in combination.

Deciphera Pharmaceuticals is a biopharmaceutical company. The company is engaged in commercial preparations to support the potential Untied States launch of ripretinib for the treatment of patients with gastrointestinal stromal tumors (GIST) who have received prior treatment with imatinib, sunitinib, and regorafenib. In addition, the company is studying ripretinib in its global pivotal Phase 3 study, INTRIGUE, in second-line GIST patients, comparing ripretinib to sunitinib. The company is developing other clinical-stage drug candidates, DCC-3014 and rebastinib, which target the macrophage tumor microenvironment. Additionally, the company is conducting preclinical investigational new drug-enabling studies with DCC-3116.

DroneShield is engaged in the development and commercialization of proprietary hardware and software acoustic technology for drone detection and security. Co.'s hardward and software detect drones up to 1km away and instantly alert users in real-time though multiple channels. Co. utilizes audio/acoustic signatures (obtained at the U.S. Department of Defence approved anechoic chamber) to detect drones more accurately when compared with traditional radar, radio frequency, camera, LIDAR and laser methods.

Dycom Industries is a provider of specialty contracting services. The company supplies telecommunications providers with a portfolio of specialty services, including program management; planning; engineering and design; aerial, underground, and wireless construction; maintenance; and fulfillment services for telecommunications providers. Additionally, the company provides underground facility locating services for various utilities, including telecommunications providers, and other construction and maintenance services for electric and gas utilities. The company supplies the labor, tools, and equipment necessary to provide these services to its customers.

Esperion Therapeutics is a pharmaceutical company that develops and commercializes oral, once-daily, non-statin medicines for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). The company's primary products, NEXLETOL? tablet and NEXLIZET? tablets, are oral, once-daily, non-statin LDL-C lowering medicines approved in the U.S. for patients with atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH). The U.S. Food and Drug Administration has approved NEXLETOL as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with HeFH or established ASCVD who require additional lowering of LDL-C.

Glaukos is an ophthalmic medical technology and pharmaceutical company focused on surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. The company developed Micro-Invasive Glaucoma Surgery (MIGS) to serve as an alternative to the glaucoma treatment and management paradigm. MIGS procedures involve the insertion of a micro-scale device or drug delivery system from within the eye's anterior chamber through a small corneal incision. The company's MIGS devices are designed to reduce intraocular pressure by restoring the natural outflow pathways for aqueous humor. The company's products include iStent trabecular micro-bypass stent, and iStent Inject trabecular micro-bypass stent.

Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in immunology, inflammation and oncology. The company has four clinical-stage product candidates: GB001 (Prostaglandin D2 receptor 2 Antagonist), which is for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions; GB002 (Platelet-derived growth factor Receptor Kinase Inhibitor), which is for the treatment of pulmonary arterial hypertension; GB004 (Hypoxia inducible factor-1a Stabilizer), which is for the treatment of inflammatory bowel disease; and GB1275 (CD11b Modulator), which is for the treatment of oncology indications.

iRhythm Technologies is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining its wearable biosensing technology with cloud-based data analytics and capabilities. The company has developed a long-term continuous ambulatory cardiac monitoring platform known as the Zio service that provides continuous ambulatory cardiac monitoring through Zio XT monitor and Zio AT monitor. While wearing either the Zio XT or Zio AT monitor, patients can mark when symptoms occur by pressing a trigger button on the device and separately recording contextual data like activities and circumstances in a written symptom diary or digitally via the myZio application.

Kaman conducts business in the aerospace, medical and industrial markets. The company produces and markets proprietary aircraft bearings and components; super precision, miniature ball bearings; proprietary spring energized seals, springs and contacts; complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing aircraft; and safe and arming solutions for missile and bomb systems for the United States and allied militaries. The company also manufactures and supports its K-MAX? manned and unmanned medium-to-heavy lift helicopters and restores, modifies and supports its SH-2G Super Seasprite maritime helicopters. The company has one business segment, Aerospace.

La-Z-Boy manufactures, markets, imports, exports, distributes and retails upholstery furniture products. In addition, the company imports, distributes and retails accessories and casegoods (wood) furniture products. The company's reportable operating segments are: Upholstery, which manufactures and imports upholstered furniture such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, ottomans and sleeper sofas; Casegoods, which imports, markets, and distributes casegoods (wood) furniture as well as manufactures some custom upholstered furniture; and Retail, which sells upholstered furniture, in addition to some casegoods and other accessories.

McCormick & Co. manufactures, markets and distributes spices, seasoning mixes, condiments and other flavor products to the food industry- retailers, food manufacturers and foodservice businesses. The company also is partner in a number of joint ventures that are involved in the manufacture and sale of flavor products. The company's business segments comprised of: consumer, in which the company markets its products to customers and supplies private label items, known as store brands; and flavor solutions, which provides a range of flavor solutions including seasoning blends, spices and herbs, condiments, coating systems and compound flavors.

Proto Labs is a digital manufacturer of custom prototypes and production parts. The company's primary manufacturing product lines include Injection Molding, which uses three-dimensional (3D) computer-aided design-to-computer numerical control (CNC) machining technology for the automated design and manufacture of molds; CNC Machining, which uses commercially available CNC machines to provide milling and turning; 3D Printing, which includes stereolithography, selective laser sintering, direct metal laser sintering, Multi Jet Fusion and PolyJet processes; and Sheet Metal, which includes e-commerce-enabled custom sheet metal parts, providing customers with prototype and low-volume production parts.

Sage Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing medicines to treat life-altering central nervous system disorders. The company's principal product candidate is ZULRESSO? (brexanolone) injection, a proprietary intravenous formulation of brexanolone for the treatment of postpartum depression (PPD). The company's other product candidate is SAGE-217, an oral compound that is being developed for PPD and major depressive disorder. The company also has a portfolio of other compounds that target GABAA receptors, which include SAGE-324 and SAGE-689. The company's second area of focus is the development of compounds that target the NMDA receptor, which include SAGE-718.

Schroder Immoplus. The fund invests mainly in residential properties in Switzerland.

Schweitzer-Mauduit International is a producer of materials, including papers, nets and films. The company operates and manages two reportable segments based on product lines: Advanced Materials and Structures, which manufactures resin-based products used in applications in the filtration, infrastructure and construction, transportation, industrial, and medical end-markets; and Engineered Papers, which produces cigarette papers and reconstituted tobacco products for cigarette and cigar manufacturers, as well as various other non-tobacco paper products.

Scotts Miracle-Gro is a manufacturer and marketer of consumer lawn and garden products in North America. The company's segments are: United States Consumer, which consists of the company's consumer lawn and garden business located in United States; Hawthorne, which consists of the company's indoor, urban and hydroponic gardening business; and Other, which consists of the company's consumer lawn and garden business in geographies other than the United States and the company's product sales to nurseries, greenhouses and other customers. The company manufactures, markets and sells lawn and garden products in the following categories: lawn care, gardening and landscape, hydroponics, and controls.

Taylor Morrison Home is a holding company. Through its subsidiaries, the company owns and operates a residential homebuilding business and is a developer of lifestyle communities. The company provides a variety of homes across a range of price points. The company operates under the Taylor Morrison and Darling Homes brand names. The company also provides financial services to customers through its mortgage subsidiary, Taylor Morrison Home Funding, LLC, title insurance and closing settlement services through its title company, Inspired Title Services, LLC, and homeowner's insurance policies through its insurance agency, Taylor Morrison Insurance Services, LLC. The company's segments are: East, Central, West and Financial Services.

TPI Composites is a holding company that conducts all of its business operations through its direct and indirect subsidiaries. The company is engaged as an independent manufacturer of composite wind blades for the wind energy market. The company is a supplier to its original equipment manufacturers customers in the manufacture of wind blades and related molding and assembly systems. The company uses its composite technology to supply composite products to the transportation market. The company's tooling solutions include wind blade patterns, molding and assembly systems, including modular tooling techniques. The company's geographic segments are: the United States, Asia, Mexico, Europe, the Middle East, Africa and India.

Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. The company's product categories are: biologics, which include Crysvita? (burosumab) for the treatment of X-linked hypophosphatemia and Mepsevii? (vestronidase alfa) for the treatment of Mucopolysaccharidosis VII; small molecules, which includes UX007 for the treatment of long-chain fatty acid oxidation disorders; and gene therapy, which includes DTX301 for the treatment of patients with ornithine transcarbamylase deficiency and DTX401 for the treatment of patients with glycogen storage disease type Ia.

uniQure is a biopharmaceutical company. Co. is engaged in the field of gene therapy, seeking to develop single treatments with potentially curative results for patients suffering from genetic and other diseases. Co. is advancing a focused pipeline of gene therapies that have been developed both internally and through partnerships, such as Co.'s collaboration with Bristol Myers-Squibb focused on cardiovascular diseases. Co. has established clinical proof-of-concept in its key indication, hemophilia B, and achieved preclinical proof-of-concept in Huntington's disease.

Westlake Chemical operates as a manufacturer and marketer of basic chemicals, vinyls, polymers and building products. The company operates in two operating segments: Olefins, which manufactures and markets polyethylene, styrene monomer and various ethylene co-products; and Vinyls, which manufactures and markets polyvinyl chloride (PVC), vinyl chloride monomer, ethylene dichloride, chlor-alkali (chlorine and caustic soda), chlorinated derivative products and ethylene, as well as manufactures and sells building products fabricated from PVC, including residential siding, trim and mouldings, pipe and fittings for various water, sewer and industrial applications, and profiles for windows and doors.